(Q40500313)

English

MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Anda Preda

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Viktor Novikov

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Martina Möglich

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Karl Turetschek

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

David M Shames

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Robert C Brasch

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Friedrich M Cavagna

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Timothy P L Roberts

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

865-873

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Regulators of Angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.20184

21 January 2018

Identifiers

10.1002/JMRI.20184

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40500313&oldid=1899401049"